Incyte Corp (INCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
Sales | 382,282 | 444,156 | 381,534 | 326,444 | 384,082 |
Cost of Goods | 18,106 | 22,359 | 22,036 | 20,260 | 14,824 |
Gross Profit | 364,176 | 421,797 | 359,498 | 306,184 | 369,258 |
Operating Expenses | 431,392 | 554,574 | 344,515 | 299,185 | 503,329 |
Operating Income | -67,110 | -132,418 | 15,019 | 7,259 | -133,247 |
Interest Expense | 385 | 373 | 204 | 384 | 5,939 |
Other Income | 27,141 | -15,486 | 28,539 | -16,259 | -58,797 |
Pre-tax Income | -40,354 | -148,277 | 43,354 | -9,384 | -197,983 |
Income Tax | 786 | 1,352 | 7,300 | 3,100 | -10,900 |
Net Income Continuous | -41,140 | -149,629 | 36,054 | -12,484 | -187,083 |
Net Income | $-41,140 | $-149,629 | $36,054 | $-12,484 | $-187,083 |
EPS Basic Total Ops | -0.19 | -0.68 | 0.17 | -0.06 | -0.96 |
EPS Basic Continuous Ops | -0.19 | -0.69 | 0.17 | -0.06 | -0.96 |
EPS Diluted Total Ops | -0.19 | -0.68 | 0.17 | -0.06 | -0.96 |
EPS Diluted Continuous Ops | -0.19 | -0.68 | 0.17 | -0.06 | -0.96 |
EBITDA(a) | $-53,686 | $-119,559 | $26,959 | $19,611 | $-118,220 |